NDC Package 0143-9169-01 Starjemza

Ustekinumab-hmny Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0143-9169-01
Package Description:
.5 mL in 1 VIAL
Product Code:
Proprietary Name:
Starjemza
Non-Proprietary Name:
Ustekinumab-hmny
Substance Name:
Ustekinumab
Usage Information:
Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.
11-Digit NDC Billing Format:
00143916901
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
0.5 ML
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Hikma Pharmaceuticals Usa Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
BLA761419
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
10-27-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0143-9169-01?

The NDC Packaged Code 0143-9169-01 is assigned to a package of .5 ml in 1 vial of Starjemza, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. The product's dosage form is injection and is administered via subcutaneous form.This product is billed per "ML" milliliter and contains an estimated amount of 0.5 billable units per package.

Is NDC 0143-9169 included in the NDC Directory?

Yes, Starjemza with product code 0143-9169 is active and included in the NDC Directory. The product was first marketed by Hikma Pharmaceuticals Usa Inc. on October 27, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0143-9169-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 0.5.

What is the 11-digit format for NDC 0143-9169-01?

The 11-digit format is 00143916901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20143-9169-015-4-200143-9169-01